Tuesday , November 21 2017
Home / Letter From The Editor / Oct 21, 2017

Oct 21, 2017

daveThis week insulin takes a front row in treating diabetes with the information on a new super rapid insulin. This insulin, discussed in this week’s item 2,  gives flexibility at meal time that has been lacking for a lot of patients.

Also, as Animas leaves the insulin pump market, a new study discussed in item 6 shows the value of using pump therapy in children, and how we can all work to reduce hypoglycemia and A1c values.


We can make a difference!


Dave Joffe